BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Operating income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.5B | −33.1% | −11.2% | 5.1% |
| Operating income (TTM) | $2.5B |
|---|---|
| YoY | −33.1% |
| 5-year CAGR | −11.2% |
| 10-year CAGR | 5.1% |
Operating income
| Period | Operating income | YoY |
|---|---|---|
| 2021 | $2.8B | −37.6% |
| 2020 | $4.6B | −35.4% |
| 2019 | $7.0B | +19.6% |
| 2018 | $5.9B | +10.2% |
| 2017 | $5.3B | +3.8% |
| 2016 | $5.2B | +5.3% |
| 2015 | $4.9B | +23.1% |
| 2014 | $4.0B | +57.9% |
| 2013 | $2.5B | +35.5% |
| 2012 | $1.9B | +7.6% |
| 2011 | $1.7B | +38.1% |
| 2010 | $1.2B | −3.6% |
| 2009 | $1.3B | +6.7% |
| 2008 | $1.2B | +55.6% |
| 2007 | $780M | — |